2016-000307-93
A study to compare two different forms of the same medicine (deferasirox tablet that is dissolved in liquid form vs. deferasirox granule form) to see how much of each type of medicine ends up in the blood.
Novartis Pharmaceuticals Corporation·EU Clinical Trials Register
Study focus
- Disease/Condition
- Healthy subjects
Sponsor & location
- Primary sponsor
- Novartis Pharmaceuticals Corporation
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
Primary outcome
-Primary PK parameters: AUClast, AUCinf and Cmax.
ICD-10 classifications
Occupational health examinationSeeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmfulRoutine child health examinationExamination and observation for other reasons
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2016-000307-93
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2016-000307-93 through Pure Global AI's free database. This phase not specified trial is sponsored by Novartis Pharmaceuticals Corporation and is currently status unknown. The study focuses on Healthy subjects.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.